Oncology

Johnson Johnson
Pharma

J&J eyes earlier myeloma treatment with ph. 3 Tecvayli combo win

J&J says it plans to present the Tecvayli combo data to health authorities and disclose the detailed myeloma results at an upcoming medical meeting.
Fraiser Kansteiner Oct 16, 2025 8:10am
Massachusetts Massachusetts flag MA MA flag

AbbVie unveils $70M expansion in MA

Oct 1, 2025 9:05am
Indiana Indiana flag

CDMO Simtra buys land for upcoming injectables expansion in US

Jul 28, 2025 3:50pm
JNJ

J&J logs strong innovative drug sales despite Stelara's decline

Jul 16, 2025 11:19am
Graphic for the Podnosis podcast by Fierce featuring a stylized heart at the center surrounded by colorful sound wave visual

AbbVie, ADCs and the future of cancer care

Jun 20, 2025 9:39am
Businessman about to be crushed by falling dominos

BioNTech to wind down cell therapy manufacturing in Maryland

Jun 18, 2025 10:23am
More News

Inside ASCO 2025: Big data drops and a towering campaign

Jun 6, 2025 10:39am

AbbVie's ADC bet pays off with FDA nod for Emrelis

May 14, 2025 3:39pm

J&J finds pace of oncology innovation is overwhelming physicians

May 7, 2025 2:10pm

Summit stock falls as Akeso shares bispecific OS data vs. Keytruda

Apr 25, 2025 4:02pm